Mostafa Mousa is an Egyptian national working as a product specialist for Pfizer Saudi Arabia. He has a BSc in Pharmacy from Tanta University in 2010. His experience includes working as an executive medical representative for Novartis Egypt from 2012 to 2014, where he achieved 40% market share for Diovan and 40-50% growth rates. Currently at Pfizer Saudi Arabia since 2014, he is responsible for promoting ENBREL and has increased its patient shares in various sectors to 53%, 45%, and 30%, exceeding his initial targets. He is seeking new career opportunities and can be contacted at the provided contact information.